MediPines Corporation develops the AGM100, a non-invasive medical device that provides rapid, accurate assessments of cardiorespiratory status through breath sampling, measuring oxygenation, ventilation, and gas exchange efficiency. This technology enables healthcare providers to quickly identify respiratory impairments and make informed diagnostic and treatment decisions at the point of care.
Funding
$5.7M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Current methods of assessing cardiorespiratory function often rely on invasive procedures or lack the speed and accuracy needed for effective point-of-care decision-making. Traditional tools may not provide a comprehensive picture of oxygenation, ventilation, and gas exchange efficiency, hindering timely diagnosis and treatment of respiratory impairments.
Solution
MediPines develops and markets the AGM100, a non-invasive device that delivers rapid and accurate cardiorespiratory assessments through breath sampling. The AGM100 measures key parameters including oxygenation, ventilation, and gas exchange efficiency, providing clinicians with comprehensive data at the point of care. This technology enables healthcare providers to quickly identify respiratory impairments, support diagnostic and treatment decisions, and monitor the effectiveness of interventions. The AGM100 aims to improve patient outcomes by offering a fast, accurate, and painless method for evaluating cardiorespiratory status across various clinical settings.
Target Audience
The primary target audience includes physicians and healthcare providers in emergency medicine, pulmonology, cardiology, anesthesiology, and general practice who require rapid and accurate cardiorespiratory assessments at the point of care.
Features
- Non-invasive breath sampling for patient comfort and ease of use
- Rapid results in under two minutes, enabling timely clinical decisions
- Accurate measurements of oxygenation, ventilation, and gas exchange efficiency
- Comprehensive assessment of cardiorespiratory status with a single device
- Applicable across various clinical settings, including emergency medicine, pulmonology, cardiology, anesthesiology, and general floor
- Supports diagnosis and treatment decisions for both chronic and acute respiratory conditions
- Objective confirmation of treatment effectiveness